Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT† [0.03%]
基于基线PET/CT的病变弥散和代谢肿瘤负荷的风险分层弥漫性大B细胞淋巴瘤
A-S Cottereau,M Meignan,C Nioche et al.
A-S Cottereau et al.
Background: We analyzed the prognostic value of a new baseline positron emission tomography (PET) parameter reflecting the spread of the disease, the largest distance between two lesions (Dmax). We tested its complementar...
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆ [0.03%]
D2根治术后II期或III期胃癌患者接受辅助S-1单药、SOX(替吉奥联合顺铂)和S-DRXTM(DCF)(替吉奥联合顺铂和氟尿嘧啶连续输注)治疗的随机III期临床研究(ARTIST 2试验)
S H Park,D H Lim,T S Sohn et al.
S H Park et al.
Background: Adjuvant chemotherapy and chemoradiotherapy are some of the standards of care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors (ARTIST) 2 trial compares two adjuvant chemotherapy regim...
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer [0.03%]
司妥昔单抗联合帕博利珠单抗一线治疗晚期非小细胞肺癌的安全性和有效性：一项1/2期试验
R Perets,J Bar,D W Rasco et al.
R Perets et al.
Background: Quavonlimab (MK-1308), a novel anti-CTLA-4 antibody, in combination with pembrolizumab was investigated in a phase I study. Patients and metho...
H Vanacker,P A Cassier,T Bachelot
H Vanacker
Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer: Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [0.03%]
肾细胞癌：欧洲肿瘤内科学会肾细胞癌临床实践指南的近期更新——卡博替尼和纳武利尤单抗作为一线治疗透明细胞型肾癌：诊断、治疗和随访欧洲肿瘤内科学会肾细胞癌临床实践指南
T Powles;ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
T Powles;ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor [0.03%]
sentinel node活检可以提高临床和病理特征对黑色素瘤患者分期的准确性
M-A El Sharouni,M D Stodell,T Ahmed et al.
M-A El Sharouni et al.
Background: It has been claimed, without supporting evidence, that knowledge of sentinel node (SN) status does not provide more accurate prognostic information than basic clinicopathological features of a primary cutaneou...
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [0.03%]
新诊断及复发滤泡性淋巴瘤的诊治和随访：欧洲肿瘤内科学会临床实践指南
M Dreyling,M Ghielmini,S Rule et al.
M Dreyling et al.
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆ [0.03%]
细胞毒性药物相关皮肤病的预防和管理：欧洲肿瘤医学学会临床实践指南
M E Lacouture,V Sibaud,P A Gerber et al.
M E Lacouture et al.
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine [0.03%]
精准医学时代胰腺癌新辅助治疗的重塑
R Casolino,C Braconi,G Malleo et al.
R Casolino et al.
This review summarises the recent evidence on preoperative therapeutic strategies in pancreatic cancer and discusses the rationale for an imminent need for a personalised therapeutic approach in non-metastatic disease. The molecular diversi...